CLINICAL_TRIALS
trial_result
· 2024-02-29
Clinical Trial Update: A Study of MD-120 in Patients With Depression [Phase 3]
Summary
Phase 3 trial update for MD-120 in major depressive disorder has completed with results posted in 2024.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mochida Pharmaceutical Company, Ltd. | Conditions: Major Depressive Disorder | Phase 3 | Status: COMPLETED | Results posted: 2024-02-29